Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2773331 Title: FORMULIERUNGEN ZUR BEHANDLUNG VON DIABETES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
127984706
WO application number:
US2012062816
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2773331
WO publication number:
WO2013067022
1rst applicant's nationality:
Translation language:
German
EPO publication language:
English
SPC number:

Dates

Filing date:
31/10/2012
Grant date:
10/02/2016
EP publication date:
10/09/2014
WO publication date:
10/05/2013
Claims translation received date:
Translation received date (EP publication B1):
03/05/2016
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
10/02/2016
EP B1 publication date:
10/02/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/10/2020
Expiration date (if granted and all annual fees paid):
31/10/2032

Applicant

Name:
Xeris Pharmaceuticals, Inc.
Legal Form:
From:
10/02/2016
Address:
3208 Red River, Suite 300, Austin TX 78705, United States (US)
To:

Agent

Name:
POWIS de TENBOSSCHE Roland
Legal Form:
From:
03/05/2016
Address:
Boulevard Général Wahis 15, 1030, BRUXELLES, Belgium (BE)
To:

Inventor

1

Name:
PRESTRELSKI, Steven
Legal Form:
Address:
Austin, TX 78705, United States (US)

2

Name:
SCOTT, Nancy
Legal Form:
Address:
Austin, TX 78705, United States (US)

Priority

1

Priority patent number:
201261609123 P
Priority date:
09/03/2012
Priority country:
United States (US)

2

Priority patent number:
201161553388 P
Priority date:
31/10/2011
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 9/00; A61K 9/14; A61K 9/19; A61K 38/22; A61K 38/28; A61K 47/20;

Publication

Bulletin

1

Bulletin heading:
EP3
Journal edition number:
2016/05
Publication date:
16/09/2019
Description:
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws

2

Bulletin heading:
VRV
Journal edition number:
2021/11
Publication date:
15/07/2021
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
201606
Publication date:
10/02/2016
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
17/10/2019
Last annual fee paid number:
8
Last annual fee paid amount:
135 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
03/05/2016 Translations 63 PDF /6/1/5/8/8/0721488516/docs/127984706_0_translations_20160512_014849359.pdf